Genotypic variants of CYP1A1 were determined using polymerase chain reaction in 81 incident cases of HCC and 409 controls nested in a cohort study of 4841 male chronic HBV carriers. This evidence concerns the gene CYP1A1 and hepatocellular carcinoma.